NetComposites
Airtech

Exova Wins Long Term Agreement With Böhler

24 February 2015

Exova Group, the global testing, calibration and advisory services provider, has signed a five-year long term agreement with Böhler Schmiedetechnik.

The new contract extends a relationship spanning more than a decade and will see Exova provide material testing programmes on high grade forged aerospace alloy components for use in aircraft engines and structural airframes.

The testing will be conducted at Exova’s aerospace laboratory in Plzen, Czech Republic and will include fatigue and fracture mechanics and a range of specialist metallurgical and mechanical testing.

Florian Humer, Strategic Procurement External Services Manager for Böhler commented “The aerospace sector demands the highest quality and technical standards and Exova has proven itself capable of meeting our rigorous testing demands. Extending our relationship supports our work to advance the development and application of specialist aerospace alloys.”

Stuart Abbs, European Director of Aerospace for Exova said: “The new contract with Böhler underlines Exova’s position as a leading provider of technically demanding services to the aerospace sector. We have made significant investment in the capabilities and capacity of our Plzen facilit, ensuring we can meet the current and future needs of Böhler and the global aerospace supply chain.”





Share this story


Related / You might like...

Cristex Keeps Pace With Composites Sector Thanks to ‘Limitless' Zünd G3 Cutter

Cristex Composites Materials has recently expanded its product offering with the addition of a new Zünd G3 precision cutting system, enabling the company to offer its customers an enhanced cut quality and precision service.

Bindatex Showcasing New Thermoplastic UD Tape Splicing Capability At JEC

Bindatex  will showcase its new thermoplastic splicing capability at JEC World 2019.

New Large Scale Resin Infusion Capabilities at NCC

The National Composites Centre (NCC) and Composite Integration celebrate the successful completion of a year-long project to design and deliver a state-of-the-art, first of its kind, Large Scale Resin Infusion (LSRI) technology.